Skip to main content

Table 2 Complications and follow-up results of voiding parameters

From: Surgical outcomes of transurethral enucleation with bipolar energy for benign prostatic hyperplasia: single surgeon’s initial experience

 

Total (n = 387)

Early group (n = 193)

Late group (n = 194)

p value

Re-operation due to bleeding

24 (6%)

19 (9.8%)

5 (2.5%)

0.002

Immediate postoperative urinary retention requiring catheterization

31 (8.0%)

15 (7.8%)

16 (8.2%)

0.988

De novo Stress Urinary incontinence (post 6 months)

8/291 (2.4%)

2/141 (1.4%)

6/150 (4.4%)

0.188

De novo Urethral stricture (post 6 months)

1/291 (0.3%)

0 (0%)

1/150 (0.8%)

0.158

De novo Bladder neck contracture (post 6 months)

1/291 (0.3%)

1/141 (0.7%)

0 (0%)

0.477

Qmax post 3 months

15.74 ± 11.73

14.40 ± 9.07

17.75 ± 14.90

0.328

PVR post 3 months

28.1 cc ± 34.0

31.9 cc ± 33.2

23.2 cc ± 35.2

0.362

Qmax post 6 months

16.91 ± 11.76

16.93 ± 11.95

16.83 ± 12.28

0.985

PVR post 6 months

26.2 cc ± 36.5

24.2 cc ± 38.7

32.1 cc ± 31.0

0.655

Overall complication

40 (10.3%)

24 (12.4%)

16 (8.2%)

0.176

CD grade I

11 (2.8%)

2 (1.0%)

9 (4.6%)

0.033

CD grade II

5 (1.3%)

3 (1.6%)

2 (1.0%)

0.013

CD grade III

24 (6%)

19 (9.8%)

5 (2.5%)

0.003

  1. CD: Clavien-Dindo; PVR: Postvoid residual urine (cc); Qmax: Maximal urinary flow rate (mL/s)